207 related articles for article (PubMed ID: 7001229)
1. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.
Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ
N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229
[TBL] [Abstract][Full Text] [Related]
2. [Blood sugar control in diabetics with the insulin pump. Comparison with discontinuous injections].
Sudre Y; Abadie JC; Marechaud R; Rossi F; Gouet D; Queron B
Sem Hop; 1982 Sep; 58(32):1801-4. PubMed ID: 6291163
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump.
Cohen AW; Liston RM; Mennuti MT; Gabbe SG
J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835
[TBL] [Abstract][Full Text] [Related]
4. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
5. Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.
Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Asakawa N; Kubota M; Kamada T
Life Support Syst; 1985; 3 Suppl 1():583-7. PubMed ID: 3916624
[TBL] [Abstract][Full Text] [Related]
6. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.
Reeves ML; Seigler DE; Ryan EA; Skyler JS
Am J Med; 1982 Apr; 72(4):673-80. PubMed ID: 7041646
[TBL] [Abstract][Full Text] [Related]
8. Normalization of plasma glucose of unstable diabetes: studies under ambulatory, fed conditions with pumped intravenous insulin.
Service FJ
J Lab Clin Med; 1978 Mar; 91(3):480-9. PubMed ID: 627751
[TBL] [Abstract][Full Text] [Related]
9. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus.
Harrower AD; Duncan LJ; Clarke BF
Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249
[TBL] [Abstract][Full Text] [Related]
10. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
Kerner W; Beischer W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
[TBL] [Abstract][Full Text] [Related]
11. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
12. Continuous intravenous insulin therapy with a miniaturized open-loop system.
Renner R; Hepp KD; Mehnert H; Franetzki M
Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
[TBL] [Abstract][Full Text] [Related]
13. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring.
De Block C; Manuel-Y-Keenoy B; Van Gaal L; Rogiers P
Diabetes Care; 2006 Aug; 29(8):1750-6. PubMed ID: 16873775
[TBL] [Abstract][Full Text] [Related]
14. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy: Part II. Multicomponent insulin regimens.
Hirsch IB; Herter CD
Am Fam Physician; 1992 Jun; 45(6):2643-8. PubMed ID: 1595513
[TBL] [Abstract][Full Text] [Related]
16. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
[TBL] [Abstract][Full Text] [Related]
17. Replacement treatment with insulin in diabetes mellitus: problems and promise.
Dupre J; Champion MC; Rodger NW
Clin Invest Med; 1982; 5(2-3):109-19. PubMed ID: 6749365
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
[TBL] [Abstract][Full Text] [Related]
20. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
